Evoke Pharma (EVOK) Posts Smaller-than-Expected Q4 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. CVS

Go back to Evoke Pharma (EVOK) Posts Smaller-than-Expected Q4 Loss

Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights

March 7, 2018 4:05 PM EST

Successfully completed pivotal pharmacokinetic trial and finalized the proposed to-be-marketed Gimoti doseAnnounced discovery of sex-based pharmacokinetic differences for GimotiMet with FDA regarding NDA women-only filing strategy and post-marketing plans505(b)(2) NDA submission planned for second quarter of 2018           

SOLANA BEACH, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter and full year ended... More